Skip to main content
. 2016 May 19;4(3):e00203. doi: 10.1002/prp2.203

Figure 1.

Figure 1

Median acute mountain sickness (AMS) scores on arrival at each new altitude during ascent with the median values of the worst AMS scores for comparison. The scores are given for placebo and benzolamide‐treated subjects at each altitude (placebo n = 13; benzolamide n = 12 intention‐to‐treat analysis).